Align Technology (NASDAQ:ALGN) Posts Quarterly Earnings Results, Misses Expectations By $0.47 EPS

Align Technology (NASDAQ:ALGN) posted its earnings results on Wednesday. The medical equipment provider reported $1.96 EPS for the quarter, missing analysts’ consensus estimates of $2.43 by ($0.47), Zacks reports. Align Technology had a return on equity of 13.99% and a net margin of 11.15%. Align Technology updated its Q1 2025 guidance to EPS.

Align Technology Price Performance

NASDAQ:ALGN opened at $218.38 on Friday. The company has a 50 day moving average price of $221.70 and a 200-day moving average price of $226.10. Align Technology has a 1-year low of $196.09 and a 1-year high of $335.40. The firm has a market cap of $16.30 billion, a price-to-earnings ratio of 37.27, a price-to-earnings-growth ratio of 4.80 and a beta of 1.67.

Analysts Set New Price Targets

Several brokerages have recently issued reports on ALGN. Evercore ISI upped their target price on shares of Align Technology from $240.00 to $260.00 and gave the company an “outperform” rating in a research report on Thursday. Piper Sandler lowered their price objective on shares of Align Technology from $275.00 to $270.00 and set an “overweight” rating for the company in a research report on Thursday. Mizuho started coverage on shares of Align Technology in a report on Wednesday, December 4th. They issued an “outperform” rating and a $295.00 price target for the company. Leerink Partners upgraded shares of Align Technology from a “market perform” rating to an “outperform” rating and raised their target price for the company from $235.00 to $280.00 in a research note on Monday, January 6th. Finally, Stifel Nicolaus decreased their price objective on shares of Align Technology from $285.00 to $275.00 and set a “buy” rating for the company in a research report on Thursday, October 24th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $271.40.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.